Menu
OR
OR
Oncolytic Vaccinia Virus-Engineered EVs Convert Tumor-Promoting Macrophages into Anti-Tumor Effectors

Surgical Oncology

...

Read Full Article

Journal Source :

Cancer Management and Research

© 2024 Imedsource, All Rights Reserved

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.